The role of endothelin-1 in hepatic ischemia and reperfusion injury

Journal of Gastroenterology

Volumn 37, Issue 9, 2002, Pages 763-765

  Jin, Maeng Bong ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; TAK 044; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL CELL; ANIMAL TISSUE; ATTENUATION; CRYOPRESERVATION; DOG; DRUG SELECTIVITY; EDITORIAL; ENDOTHELIUM CELL; HEPATIC VEIN; INHIBITION KINETICS; LEUKOCYTE ADHERENCE; LIVER DISEASE; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER SINUSOID; MEDICAL RESEARCH; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN SECRETION; REPERFUSION INJURY; TIME;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIN-1; ISCHEMIA; LIVER; RATS; REPERFUSION INJURY;

EID: 0036709117     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200127     Document Type: Editorial

References (23)

1. Yanagisawa M, Kurihara H, Kimura S, Tombe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Yanagisawa M. The endothelin system. A new target for therapeutic intervention. Circulation 1994;89:1320-2.
3. Opgenorth TJ, Wu-Wong JR, Shiosaki K. Endothelin-converting enzymes. FASEB J 1992;6:2653-9.
4. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
5. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992;13:103-8.
6. Teerlink JR, Carteaux JP, Sprecher URS, Loffler BM, Clozel M, Clozel JP. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am J Physiol 1995;268:H432-40.
7. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentillini A, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110:534-48.
8. Housset C, Laudat A, Chung JJ, Rockey DC. Expression and potential role of endothelin in cholestatic liver injury (abstract). Hepatology 1995;22:278.
9. Urakami A, Todo S, Zhu Y, Zhang S, Jin MB, Ishizaki N, et al. Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody. AwETN40. J Am Coll Surg 1997;185:358-64.
10. Ishizaki N, Zhu Y, Zhang S, Nemoto A, Kobayashi Y, Subbotin VM, et al. Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation 1997;63:202-8.
11. Yokota R, Fukai M, Shimamura T, Suzuki T, Watanabe Y, Nagashima K, et al. A novel hydroxy radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. Surgery 2000;127:661-9.
12. Todo S, Zhu Y, Zhang S, Jin MB, Ishizaki N, Tanaka H, et al. Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997;63:217-23.
13. Shimamura T, Zhu Y, Zhang S, Jin MB, Ishizaki N, Urakami A, et al. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 1999;188:43-52.
14. Totsuka E, Todo S, Zhu Y, Ishizaki N, Kawashima Y, Jin MB, et al. Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin 12 analogue, OP-41483. J Am Coll Surg 1998;187;276-86.
15. Ishikawa H, Jin MB, Ogata T, Taniguchi M, Suzuki T, Shimamura T, et al. Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. Transplantation 2002;73:1041-8.
16. Ogata K, Jin MB, Taniguchi M, Suzuki T, Shimamura T, Kitagawa. N, et al. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. Transplantation 2001;71:1040-6.
17. Masuko H, Jin MB, Horiuchi H, Suzuki T, Taniguchi M, Shimamura T, et al. Protective effect of angiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation 2001;71:1034-9.
18. Jin MB, Zhu Y, Zhang S, Ishizaki N, Tanaka H, Subbotin VW, et al. Attenuation of ischemia liver injury by a non-selective endothelin receptor antagonist. Transplantation Proc 1997;29: 1335.
19. Okumura S, Takei Y, Kawano S, Nagano K, Masuda E, Goto M, et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994;19:155-61.
20. Kaneda K, Ekataksin W, Sogawa M, Matsumura A, Cho A, Kawada N. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 1998;27:735-47.
21. Charrueau CA, Carayon A, Thurman RG. Long-term cold liver storage induces endothelin-1 release and a time-dependent increase in portal pressure at reperfusion in the rat. J Gastroenterology 2002;37:717-25.
22. Boros M, Massberg S, Baranyl L, Okada H, Messmer K. Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine. Gastroenterology 1998;114:103-14.
23. Dhar DK, Yamanoi A, Ohmori H, Nakashima Y, Yamamoto A, Osama NE, et al. Modulation of endothelin and nitric oxide: a rational approach to improve canine hepatic microcirculation. Hepatology 1998:28:782-8.